| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| CAREMAX Aktie jetzt für 0€ handeln |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| UNITEDHEALTH | 372,40 | +0,59 % | UnitedHealth hebt Prognose an - Erholung bestätigt | UnitedHealth überraschte die Börse am Donnerstag mit einem starken Abschluss. Die Zahlen für das 2. Quartal und der neue Jahresausblick lagen über den Schätzungen und auch den eingepreisten Erwartungen.... ► Artikel lesen | |
| INTUITIVE SURGICAL | 302,00 | -14,19 % | Opening Bell: IBM, Netflix, Intuitive Surgical, Alphabet, SpaceX | Die Wall Street hat am Donnerstag schwächer tendiert. Der Dow Jones startete zunächst höher und legte zwischenzeitlich weiter zu, rutschte im Verlauf jedoch in die Verlustzone. Am Ende verlor der Leitindex... ► Artikel lesen | |
| THERMO FISHER | 466,90 | -1,04 % | Thermo Fisher Scientific declares $0.47 dividend | ||
| ATOSSA THERAPEUTICS | 2,080 | -0,95 % | Atossa Therapeutics Inc: Atossa Therapeutics Announces Closing of Registered Direct Offering of up to $16.5 Million in Gross Proceeds | $4.5 million upfront with up to an additional $12 million of potential aggregate gross proceeds upon exercise in full of warrants
SEATTLE, June 12, 2026 /PRNewswire/... ► Artikel lesen | |
| EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc. - 8-K, Current Report | ||
| CENTENE | 55,90 | +0,07 % | Molina, Centene, and Oscar are down after Elevance Health's Q2 report | ||
| QUIDELORTHO | 15,070 | -5,07 % | QuidelOrtho Corp - S-8, Securities to be offered to employees in employee benefit plans | ||
| VERU | 2,380 | 0,00 % | Top Biotech Gainers: VERU Teams Up With NVO, ABSI On Watch, ALVO Resubmits BLAs To FDA... | REYKJAVIK (dpa-AFX) - Thursday's top gainers include Veru, following a Novo Nordisk collaboration; Health Catalyst, following a divestment of its revenue workflow and analytics software business... ► Artikel lesen | |
| TEMPEST THERAPEUTICS | 0,966 | 0,00 % | Tempest Therapeutics: Tempest Unveils Next-Generation In Vivo CAR-T Pipeline, with First Clinical Study Planned for the Fourth Quarter of 2026 | Advancing a pipeline of in vivo CAR-T product candidates for oncology and immunology applications differentiated by CD7-targeted mRNA/LNP delivery approachLead candidate TPST-4003 combines proprietary... ► Artikel lesen | |
| NANO-X IMAGING | 1,120 | +7,69 % | NANO-X IMAGING LTD: New Clinical Study Data, Featuring Nanox.AI Cardiac Solution to Be Presented at SCCT 2026 | New SCCT abstracts from Brigham and Women's Hospital highlight the performance and clinical utility of Nanox.AI's FDA-cleared cardiac AI solution, showing high agreement with expert assessment and its... ► Artikel lesen | |
| FULGENT GENETICS | 17,600 | -1,68 % | Fulgent reports interim data for cancer drug FID-007 trial | ||
| LANTHEUS | 91,70 | 0,00 % | Lantheus Holdings, Inc.: Lantheus Receives Complete Response Letter from FDA for LNTH-2501 (Ga 68 edotreotide) | BEDFORD, Mass., June 26, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. ("Lantheus" or "Company") (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians... ► Artikel lesen | |
| PERSPECTIVE THERAPEUTICS | 2,584 | +1,10 % | Perspective Therapeutics, Inc.: Perspective Therapeutics Appoints Paul Lyne, Ph.D., as Chief Science Officer; Co-Founder Michael K. Schultz, Ph.D., Transitions to Senior Scientific Advisor | SEATTLE, July 08, 2026 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. ("Perspective," the "Company," "we," "us," and "our") (NYSE AMERICAN: CATX), a radiopharmaceutical development company pioneering... ► Artikel lesen | |
| OMNICELL | 41,200 | 0,00 % | KeyBanc reiterates Omnicell stock rating on Titan XT launch | ||
| AMN HEALTHCARE SERVICES | 29,400 | +5,76 % | Why AMN Healthcare Services (AMN) is a Top Momentum Stock for the Long-Term |